Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heart Matters: Cardiac Dysfunction and Other Autonomic Changes in Parkinson’s Disease
V Gonçalves, Lorena Cuenca‐Bermejo, Emiliano Fernández‐Villalba, et al.
The Neuroscientist (2021) Vol. 28, Iss. 6, pp. 530-542
Closed Access | Times Cited: 21

Showing 21 citing articles:

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Nervous System Disorders: A Systematic Review and Meta-Analysis
Bo Xu, Mingxia Yang, Shaoqian Li, et al.
Annals of Pharmacotherapy (2025)
Closed Access | Times Cited: 2
Cardiac Changes in Parkinson’s Disease: Lessons from Clinical and Experimental Evidence
Lorena Cuenca‐Bermejo, Pilar Almela, Javier Navarro‐Zaragoza, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13488-13488
Open Access | Times Cited: 28
Targeting exercise intensity and aerobic training to improve outcomes in Parkinson’s disease
Tone Ricardo Benevides Panassollo, Grant Mawston, Denise Taylor, et al.
Sport Sciences for Health (2024) Vol. 20, Iss. 2, pp. 287-297
Open Access | Times Cited: 4
Cardiovascular disorders in Parkinson's disease
V. V. Yudina, О. N. Voskresenskaya
Russian neurological Journal (2025) Vol. 29, Iss. 6, pp. 15-19
Closed Access
Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet
Manal M. Khowdiary, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European Journal of Pharmacology (2025), pp. 177419-177419
Open Access
Intact microdissection of stellate ganglia in a Parkinson's disease model reveals aggregation of mutant human α‐synuclein in their cell bodies
Bonn Lee, Shiraz Ahmad, Charlotte E. Edling, et al.
Experimental Physiology (2025)
Open Access
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Qiu Jiang, Jie Liu, Shan Huang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Advances in autonomic dysfunction research in Parkinson’s disease
Huichun Xu, Xiaolei Zheng, Xinyue Xing, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Cardiovascular health and its association with dementia, Parkinson’s Disease, and mortality among UK older adults
Michael F. Georgescu, May A. Beydoun, Jordan Weiss, et al.
Brain Behavior & Immunity - Health (2025), pp. 100986-100986
Open Access
Nature’s Remedies: Exploring the Potential of Propolis to Alleviate Non-Motor Manifestations of Parkinson’s Disease
Kételin Vitória Matias, V Gonçalves, Fulvio Alexandre Scorza, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1672-1672
Open Access
Investigating the Interplay between Cardiovascular and Neurodegenerative Disease
J. Cousineau, Aimee Maria Dawe, Melanie Alpaugh
Biology (2024) Vol. 13, Iss. 10, pp. 764-764
Open Access | Times Cited: 3
Establishing the Correlation between Parkinson's and Heart Disease using Machine Learning Algorithm
Naman Kumar, Sandhya Avasthi, Ayushi Prakash
(2023), pp. 581-586
Closed Access | Times Cited: 6
123I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation
Paola Gargiulo, Wanda Acampa, Gaetano Asile, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 3, pp. 813-824
Open Access | Times Cited: 10
Risk of myocardial infarction in Parkinson's disease: A systematic review and meta‐analysis
Fardin Nabizadeh, Parya Valizadeh, Parisa Sharifi, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 8, pp. 2557-2569
Closed Access | Times Cited: 5
Clinical and Non-Clinical Cardiovascular Disease Associated Pathologies in Parkinson’s Disease
Bonn Lee, Charlotte E. Edling, Shiraz Ahmad, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12601-12601
Open Access | Times Cited: 5
The Brain Region Specific Citrullinome and PAD 1-6 Isozyme Detection in a Pre-motor Parkinson’s Disease Rat Model
Audrey Mercer, Marco Sancandi, Amy MacLatchy, et al.
(2024)
Open Access | Times Cited: 1
Brain-Region-Specific Differences in Protein Citrullination/Deimination in a Pre-Motor Parkinson’s Disease Rat Model
Audrey Mercer, Marco Sancandi, Amy MacLatchy, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11168-11168
Open Access | Times Cited: 1
Shisandra Decoction Alleviates Parkinson’s Disease Symptoms in a Mouse Model Through PI3K/AKT/mTOR Signalling Pathway
Yawen Pan, Mojinzi Chen, Lulu Pan, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2011-2027
Open Access | Times Cited: 1
Propolis induces cardiac metabolism changes in 6-hydroxydopamine animal model: A dietary intervention as a potential cardioprotective approach in Parkinson’s disease
V Gonçalves, Victor Silva da Fonsêca, Daniele de Paula Faria, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Age and Sex Determine Electrocardiogram Parameters in the Octodon degus
Lorena Cuenca‐Bermejo, María Josefa Fernández del Palacio, V Gonçalves, et al.
Biology (2023) Vol. 12, Iss. 5, pp. 747-747
Open Access | Times Cited: 1
Re. “To bee or not to bee? The bee extract propolis as a bioactive compound in the burden of lifestyle diseases”
Fúlvio A. Scorza, Ana C. Fiorini, Antonio‐Carlos G. de Almeida, et al.
Nutrition (2021) Vol. 93, pp. 111241-111241
Closed Access
Page 1

Scroll to top